KLP Kapitalforvaltning AS acquired a new stake in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 42,500 shares of the company's stock, valued at approximately $1,648,000.
A number of other institutional investors have also made changes to their positions in the company. Golden State Wealth Management LLC acquired a new stake in Bath & Body Works during the 4th quarter valued at $26,000. SRS Capital Advisors Inc. lifted its holdings in Bath & Body Works by 99.7% in the 4th quarter. SRS Capital Advisors Inc. now owns 659 shares of the company's stock worth $26,000 after buying an additional 329 shares in the last quarter. True Wealth Design LLC boosted its position in Bath & Body Works by 5,270.0% in the 3rd quarter. True Wealth Design LLC now owns 1,074 shares of the company's stock valued at $34,000 after buying an additional 1,054 shares during the last quarter. UMB Bank n.a. grew its stake in shares of Bath & Body Works by 58.8% during the fourth quarter. UMB Bank n.a. now owns 905 shares of the company's stock valued at $35,000 after acquiring an additional 335 shares in the last quarter. Finally, Lindbrook Capital LLC increased its position in shares of Bath & Body Works by 81.9% during the fourth quarter. Lindbrook Capital LLC now owns 957 shares of the company's stock worth $37,000 after acquiring an additional 431 shares during the last quarter. 95.14% of the stock is owned by institutional investors and hedge funds.
Bath & Body Works Stock Performance
Shares of Bath & Body Works stock traded up $1.22 on Wednesday, reaching $31.85. 4,262,829 shares of the company were exchanged, compared to its average volume of 4,522,168. The firm has a market cap of $6.82 billion, a price-to-earnings ratio of 7.77, a P/E/G ratio of 0.92 and a beta of 1.89. Bath & Body Works, Inc. has a 1-year low of $26.21 and a 1-year high of $52.99. The company's 50-day moving average is $34.84 and its two-hundred day moving average is $34.16.
Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings data on Thursday, February 27th. The company reported $2.09 EPS for the quarter, topping analysts' consensus estimates of $2.04 by $0.05. The firm had revenue of $2.79 billion during the quarter, compared to the consensus estimate of $2.78 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. As a group, sell-side analysts forecast that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.
Bath & Body Works declared that its board has approved a stock repurchase program on Thursday, February 27th that permits the company to repurchase $500.00 million in shares. This repurchase authorization permits the company to reacquire up to 6.4% of its stock through open market purchases. Stock repurchase programs are often an indication that the company's management believes its shares are undervalued.
Bath & Body Works Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, March 7th. Investors of record on Friday, February 21st were issued a $0.20 dividend. The ex-dividend date was Friday, February 21st. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.51%. Bath & Body Works's dividend payout ratio (DPR) is presently 21.98%.
Wall Street Analysts Forecast Growth
A number of research analysts recently commented on BBWI shares. Piper Sandler increased their price target on Bath & Body Works from $36.00 to $39.00 and gave the company a "neutral" rating in a report on Monday, January 6th. Raymond James reissued an "outperform" rating and set a $46.00 price target (up previously from $42.00) on shares of Bath & Body Works in a research report on Tuesday, February 25th. TD Cowen upped their price target on shares of Bath & Body Works from $42.00 to $48.00 and gave the company a "buy" rating in a report on Thursday, December 12th. Wells Fargo & Company upgraded shares of Bath & Body Works from an "equal weight" rating to an "overweight" rating and increased their price objective for the company from $42.00 to $48.00 in a research note on Friday, January 10th. Finally, Cowen reissued a "buy" rating on shares of Bath & Body Works in a research report on Thursday, February 27th. Five analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $45.06.
Read Our Latest Report on BBWI
Bath & Body Works Company Profile
(
Free Report)
Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Featured Articles
Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
